BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 25611565)

  • 1. Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling.
    Yang Z; Liu Y; Liao J; Gong C; Sun C; Zhou X; Wei X; Zhang T; Gao Q; Ma D; Chen G
    FEBS J; 2015 Mar; 282(6):1111-25. PubMed ID: 25611565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin induces protective autophagy and apoptosis through ER stress via the p-STAT3/Bcl-2 axis in ovarian cancer.
    Liu Y; Gong W; Yang ZY; Zhou XS; Gong C; Zhang TR; Wei X; Ma D; Ye F; Gao QL
    Apoptosis; 2017 Apr; 22(4):544-557. PubMed ID: 28188387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment.
    Hasan AA; Kalinina E; Nuzhina J; Volodina Y; Shtil A; Tatarskiy V
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells.
    Hu JL; Hu XL; Guo AY; Wang CJ; Wen YY; Cang SD
    Oncotarget; 2017 Jul; 8(30):49380-49394. PubMed ID: 28537902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer.
    Han Z; Hong Z; Gao Q; Chen C; Hao Z; Ji T; Hu W; Yan Y; Feng J; Liao S; Wu P; Wang D; Wang S; Zhou J; Ma D
    Hum Gene Ther; 2012 Jan; 23(1):32-45. PubMed ID: 21875334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer.
    Ji T; Gong D; Han Z; Wei X; Yan Y; Ye F; Ding W; Wang J; Xia X; Li F; Hu W; Lu Y; Wang S; Zhou J; Ma D; Gao Q
    Cancer Lett; 2013 Dec; 341(2):231-9. PubMed ID: 23962558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.
    Zhu X; Shen H; Yin X; Long L; Chen X; Feng F; Liu Y; Zhao P; Xu Y; Li M; Xu W; Li Y
    Oncotarget; 2017 Jun; 8(24):39154-39166. PubMed ID: 28388577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound K Induces Endoplasmic Reticulum Stress and Apoptosis in Human Liver Cancer Cells by Regulating STAT3.
    Zhang X; Zhang S; Sun Q; Jiao W; Yan Y; Zhang X
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29921768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
    Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
    Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
    Gao X; Wang B; Wei X; Men K; Zheng F; Zhou Y; Zheng Y; Gou M; Huang M; Guo G; Huang N; Qian Z; Wei Y
    Nanoscale; 2012 Nov; 4(22):7021-30. PubMed ID: 23044718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ID1 confers cancer cell chemoresistance through STAT3/ATF6-mediated induction of autophagy.
    Meng J; Liu K; Shao Y; Feng X; Ji Z; Chang B; Wang Y; Xu L; Yang G
    Cell Death Dis; 2020 Feb; 11(2):137. PubMed ID: 32080166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway.
    Bai L; Wang A; Zhang Y; Xu X; Zhang X
    Exp Cell Res; 2018 May; 366(2):161-171. PubMed ID: 29548748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage.
    Wu Y; Ma C; Zhao H; Zhou Y; Chen Z; Wang L
    Reprod Biol Endocrinol; 2018 Sep; 16(1):85. PubMed ID: 30176887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin.
    Hu W; Jin P; Liu W
    Cell Physiol Biochem; 2016; 38(3):1199-208. PubMed ID: 26982182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
    Tao L; Huang G; Wang R; Pan Y; He Z; Chu X; Song H; Chen L
    Sci Rep; 2016 Dec; 6():38408. PubMed ID: 27922075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
    Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
    Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer.
    Li N; Sun C; Zhou B; Xing H; Ma D; Chen G; Weng D
    PLoS One; 2014; 9(7):e100314. PubMed ID: 24999622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 overexpression reduces cisplatin cytotoxicity by decreasing ER-mitochondrial Ca2+ signaling in SKOV3 cells.
    Xu L; Xie Q; Qi L; Wang C; Xu N; Liu W; Yu Y; Li S; Xu Y
    Oncol Rep; 2018 Mar; 39(3):985-992. PubMed ID: 29286126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells.
    Yue P; Zhang X; Paladino D; Sengupta B; Ahmad S; Holloway RW; Ingersoll SB; Turkson J
    Oncogene; 2012 May; 31(18):2309-22. PubMed ID: 21909139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.